Cyclerion Therapeutics, Inc.CYCNNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank88
3Y CAGR+7.6%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+7.6%/yr
Annual compound
Percentile
P88
Within normal range
vs 3Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 41.92% |
| 2023 | 88.06% |
| 2022 | 14.66% |
| 2021 | 33.62% |
| 2020 | 36.75% |
| 2019 | -6.73% |
| 2018 | -22.71% |
| 2017 | -47.78% |
| 2016 | 0.00% |